A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer (vol 350, pg 1081, 2004)

被引:0
作者
Coombes, RC
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2461 / 2461
页数:1
相关论文
共 50 条
  • [41] Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3-A randomized, placebo-controlled clinical trial
    Goss, P. E.
    Ingle, J. N.
    Ales-Martinez, J.
    Cheung, A.
    Chlebowski, R. T.
    Wactawski-Wende, J.
    McTiernan, A.
    Robbins, J.
    Johnson, K.
    Martin, L.
    Winquist, E.
    Sarto, G.
    Garber, J. E.
    Fabian, C. J.
    Pujol, P.
    Maunsell, E.
    Farmer, P.
    Gelmon, K. A.
    Tu, D.
    Richardson, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [42] Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3-A randomized, placebo-controlled clinical trial
    Goss, P. E.
    Ingle, J. N.
    Ales-Martinez, J.
    Cheung, A.
    Chlebowski, R. T.
    Wactawski-Wende, J.
    McTiernan, A.
    Robbins, J.
    Johnson, K.
    Martin, L.
    Winquist, E.
    Sarto, G.
    Garber, J. E.
    Fabian, C. J.
    Pujol, P.
    Maunsell, E.
    Farmer, P.
    Gelmon, K. A.
    Tu, D.
    Richardson, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
    Paridaens, R
    Dirix, L
    Lohrisch, C
    Beex, L
    Nooij, M
    Cameron, D
    Biganzoli, L
    Cufer, T
    Duchateau, L
    Hamilton, A
    Lobelle, JP
    Piccart, M
    ANNALS OF ONCOLOGY, 2003, 14 (09) : 1391 - 1398
  • [44] Results of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer
    van de Velde, C.
    Seynaeve, C.
    Hasenburg, A.
    Rea, D.
    Vannetzel, J. M.
    Paridaens, R.
    Markopoulos, C.
    Smeets, J.
    Nortier, J. W. R.
    Jones, S. E.
    EJC SUPPLEMENTS, 2009, 7 (03): : 1 - 1
  • [46] The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer
    Jones, Stephen
    Stokoe, Christopher
    Sborov, Mark
    Braun, Marcus
    Ethirajan, Sukumar
    Kutteh, Leila
    Pippen, John
    Patel, Mrugesh
    Paul, Devchand
    Blum, Joanne L.
    Holmes, Frankie Ann
    Myron, Mark C.
    Cantrell, James
    Hartung, Nichole L.
    Look, Regan M.
    Di Salle, Enrico
    Davis, Jennifer C.
    Ilegbodu, Des
    Asmar, Lina
    CLINICAL BREAST CANCER, 2008, 8 (06) : 527 - 532
  • [47] Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
    Gil J.M.
    Rubio-Terrés C.
    del Castillo-Saiz A.
    González P.
    Canorea F.
    Clinical and Translational Oncology, 2006, 8 (5) : 339 - 348
  • [48] Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. (vol 369, pg 559, 2007)
    Coombes, R. C.
    Kilburn, L. S.
    Snowdon, C. F.
    LANCET, 2007, 369 (9565) : 906 - 906
  • [49] Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy (vol 99, pg 727, 2007)
    Veronesi, Umberto
    Maisonneuve, Patrick
    Rotmensz, Nicole
    Bonanni, Bernardo
    Boyle, Peter
    Viale, Giuseppe
    Costa, Alberto
    Sacchini, Virgilio
    Travaglini, Roberto
    D'Aiuto, Giuseppe
    Oliviero, Pasquale
    Lovison, Francesco
    Gucciardo, Giacomo
    del Turco, Marco Rosselli
    Muraca, Maria Grazia
    Pizzichetta, Maria Antonietta
    Conforti, Serafino
    Decensi, Andrea
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (06): : 995 - 995
  • [50] A randomized trial of tamoxifen with or without breast radiation in women with early breast cancer 50 years of age and older
    Fyles, A
    McCready, D
    Manchul, L
    Trudeau, M
    Merante, P
    Pintilie, M
    Weir, L
    Olivotto, I
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S14 - S14